ASHP Therapeutic Position Statement on the Use of Second-Generation Antipsychotic Medications in the Treatment of Adults with Psychotic Disorders

2019 ◽  
pp. 719-731
2004 ◽  
Vol 14 (3) ◽  
pp. 372-394 ◽  
Author(s):  
Jennifer Cheng-Shannon ◽  
James J. McGough ◽  
Caroly Pataki ◽  
James T. McCracken

CNS Spectrums ◽  
2004 ◽  
Vol 9 (S9) ◽  
pp. 24-31 ◽  
Author(s):  
Peter F. Buckley

ABSTRACTDosing patterns with second-generation antipsychotic medications (SGAs) are dynamic, with some SGAs surpassing current recommendations while others are declining in dose since their initial regulatory guidelines. Pertinent recent studies and available pharmacoepidemiologic reports, information, and expert consenses are reviewed herein to illuminate current thinking on the topic of dosing with SGAs. There is a need for fixed-dose studies of each SGA. Additionally, dosing should be a primary consideration when designing and subsequently interpreting comparative studies between SGAs.


2011 ◽  
Vol 38 (4) ◽  
pp. 845-853 ◽  
Author(s):  
M. Olfson ◽  
T. Gerhard ◽  
C. Huang ◽  
J. A. Lieberman ◽  
W. V. Bobo ◽  
...  

2011 ◽  
Vol 131 (1-3) ◽  
pp. 127-132 ◽  
Author(s):  
Julie Kreyenbuhl ◽  
Eric P. Slade ◽  
Deborah R. Medoff ◽  
Clayton H. Brown ◽  
Benjamin Ehrenreich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document